CHARLES SCHWAB INVESTMENT MANAGEMENT INC - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$290,000
+4.3%
58,865
+5.2%
0.00%
Q3 2016$278,000
+1.8%
55,939
+4.6%
0.00%
Q2 2016$273,000
-9.6%
53,481
+1.4%
0.00%
Q1 2016$302,000
-43.9%
52,725
+1.8%
0.00%
-100.0%
Q4 2015$538,000
-84.0%
51,807
-71.6%
0.00%
-80.0%
Q3 2015$3,370,000
-7.3%
182,409
-2.4%
0.01%0.0%
Q2 2015$3,636,000
+410.0%
186,833
+361.0%
0.01%
+400.0%
Q1 2015$713,000
-2.6%
40,532
-11.4%
0.00%0.0%
Q4 2014$732,000
+30.5%
45,762
+2.7%
0.00%0.0%
Q3 2014$561,000
-17.6%
44,542
+2.2%
0.00%0.0%
Q2 2014$681,000
+38.7%
43,578
+16.6%
0.00%0.0%
Q1 2014$491,000
-15.8%
37,382
+3.1%
0.00%0.0%
Q4 2013$583,000
-0.2%
36,242
+3.9%
0.00%0.0%
Q3 2013$584,000
+74.9%
34,874
+5.6%
0.00%0.0%
Q2 2013$334,00033,0310.00%
Other shareholders

There were no reported owners of OSIRIS THERAPEUTICS INC NEW in Q4 2013.

NameSharesValueWeighting ↓
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders